Cited by 450Health Systems, Economic Evaluations, Quality of LifeMeta-analysis and systematic reviewsDelphi Technique in Research

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

Open access

Husereau, Don, Drummond, Michael, Augustovski, Federico, de Bekker-Grob, Esther, Briggs, Andrew H., Carswell, Chris, Caulley, Lisa, Chaiyakunapruk, Nathorn, Greenberg, Dan, Loder, Elizabeth, Mauskopf, Josephine, Mullins, C. Daniel, Petrou, Stavros, Pwu, Raoh-Fang, Staniszewska, Sophie, on behalf of CHEERS 2022 ISPOR Good Research Practices Task Force·2022·BMC Medicine

DOI 10.1186/s12916-021-02204-0PMC PMC8753858

Open this paper in CoChat — free account Open PDF

Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s12916-021-02204-0

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Self-citation
GRIPP2 reporting checklists: Tools to improve reporting of patient and public involvement in research
Staniszewska, S., Brett, J., Simera, I., Seers, K., Mockford, C., Goodlad, S., Altman, D. G., Moher, D., Barber, R., Denegri, S., et al. (2017) · BMJ · doi:10.1136/bmj.j3453 · Cited by 1,983
Self-citation
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Self-citation
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
Staniszewska, S., Brett, J., Simera, I., Seers, K., Mockford, C., Goodlad, S., Altman, D. G., Moher, D., Barber, R., Denegri, S., et al. (2017) · Research Involvement and Engagement · doi:10.1186/s40900-017-0062-2 · Cited by 1,643
Self-citation
Guidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
Recommendations for Reporting Cost-effectiveness Analyses
Siegel, J. E. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540160061034 · Cited by 1,147
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan, S., Mauskopf, J., Augustovski, F., Caro, J., Lee, K. M., Minchin, M., Orlewska, E., Penna, P., Barrios, J. R. R., & Shau, W. (2014) · Value in Health · doi:10.1016/j.jval.2013.08.2291 · Cited by 1,069
Self-citation

Show all 46 references

Research works printed but not linked: 2

Walker DG, Wilson RF, Sharma R, et al. Best practices for conducting economic evaluations in health care: a systematic review of quality assessment tools. Agency Healthc Res Qual. 2012; https://www.ncbi.nlm.nih.gov/books/NBK114545/. Accessed 21 July 2021.
Drummond M. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.

Sorted by citations

Items 101–200 of 450

Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devices: a systematic review and cost-effectiveness analysis
Kenny, R. P. W., Bhattarai, N., O’Connor, N., Gonzalez-Moral, S. G., O’Keefe, H., Hosseini-Jebeli, S., Meader, N., & Rice, S. J. C. (2025) · Health Technology Assessment · doi:10.3310/ppoh2916 · Cited by 5
Cost-Effectiveness in Critical Care: A Systematic Review of Empirical Evaluations
Tatsis, F., Gouva, M., Dragioti, E., Veroniki, F., Stamatis, K., Παπαθανάκος, Γ., & Koulouras, V. P. (2025) · Healthcare · doi:10.3390/healthcare13212783 · Cited by 6
Cost-effectiveness analysis of a 'Termination of Resuscitation' protocol for the management of out-of-hospital cardiac arrest.
Nazeha, N., Mao, D. R.-H., Hong, D., Shahidah, N., Chua, I. S. Y., Ng, Y. Y., Leong, B. S., Ling, T.-A., Chia, M. Y., Ng, W., et al. (2024) · Resuscitation · doi:10.1016/j.resuscitation.2024.110323 · Cited by 6
Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective
Gregg, E., Graziadio, S., Green, W., Afonso, D., Garrett, M., Watts, K., Watkins, D., Carrol, E. D., Cooke, J., & Felton, T. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf016 · Cited by 5
Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines
Penko, J. M., Bellows, B. K., Hennessy, S., Kazi, D. S., Boylan, R. D., Zhang, Y., Coxson, P. G., Goldman, L., Bibbins-Domingo, K. B., & Moran, A. E. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011872 · Cited by 5
Economic Evaluation of Intraocular Lens Targeting Cataract Patients: A Review and Future Directions
Wu, Z., Cheng, F., & Xu, J. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.8.30 · Cited by 5
Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden
Silfverschiöld, M., Carlwig, K., Jarl, J., Greiff, L., Nilsson, P. G., Wennerberg, J. P., Zackrisson, B., Östensson, E., & Sjövall, J. (2023) · The European Journal of Health Economics · doi:10.1007/s10198-023-01578-7 · Cited by 5
A Review of Cost-Effectiveness Analyses for Open Angle Glaucoma Management
Sood, S., Iskander, M., Heilenbach, N., Chen, D. K., & Al‐Aswad, L. A. (2023) · Journal of Glaucoma · doi:10.1097/ijg.0000000000002249 · Cited by 5
Systematic review on the cost of seasonal malaria chemoprevention (SMC)
Ruisch, A., Iodice, M., Mathur, I., Harris, S., Walker, D. G., Owusu, R., Nonvignon, J., & Gilmartin, C. (2024) · Malaria Journal · doi:10.1186/s12936-024-05217-1 · Cited by 5
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
Nicholls, S. J., Ray, K. K., Lincoff, A. M., Sarnes, E., Gillard, K. K., Bloedon, L., Migliaccio-Walle, K., Elsea, D., & Nissen, S. E. (2026) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00753-w · Cited by 4
Healthy grocery delivery in the usual care for adults recovering from an acute coronary event: protocol for a three-arm randomised controlled trial
Reynolds, A. N., Hood, F. E., Wilson, R., Ross, A. B., Neumann, S., Turner, R. M., Iosua, E. E., Katare, R., Shahin, A., Kok, Z.-Y., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074278 · Cited by 5
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment
Haridoss, M., Sasidharan, A., Sajith Kumar, S., Rajsekar, K., Venkataraman, K., & Bagepally, B. S. (2024) · Applied Health Economics and Health Policy · doi:10.1007/s40258-024-00898-w · Cited by 4
Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands
Slob, B. P. H., Fens, T., Weersma, M., Postma, M. J., Boersma, C., & de Jong, L. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315509 · Cited by 4
Economic returns on investing in early childhood development in Vietnam: a cost-benefit analysis
Baek, Y., Fisher, J., Tran, T. D., Owen, A. J., Nguyen, T. T., Luchters, S. M. F., Hipgrave, D. B., Hanieh, S., Tran, T., Ha, T. T., et al. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12516-z · Cited by 4
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectable hepatocellular carcinoma: a cost–utility analysis in China and the United States
Zhao, Q., He, Y., Nian, Z., Huang, Y., Huang, R., Lai, L., & Yang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1404389 · Cited by 4
Low-dose calcium supplementation during pregnancy in low and middle-income countries: A cost-effectiveness analysis
Saronga, H. P., Dwarkanath, P., Cui, H., Muhihi, A. J., Kurpad, A. V., Poornima, V. S., Sando, M. M., Poornima, R., Yelverton, C. A., Masanja, H., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004002 · Cited by 4
Digital Versus In-Person Physical Therapy in Adults With Musculoskeletal Conditions: Retrospective Matched-Cohort Analysis of Surgery and Low-Value Surgical Rates
Domingues, B., Pereira, A. P. D., Pradhan, A., Zidde, C., Janela, D., Marramaque, C., Bento, V., Yanamadala, V., Cohen, S. P., Belz, L., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/82573 · Cited by 4
Mobile crisis effectiveness: a systematic review and associated functions and forms framework
Peters, R. L., Fine, J., Newton, H., Dalack, G. W., Watson, A. C., & Lich, K. H. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13806-2 · Cited by 7
Impact of hemodynamic management guided by intracranial compliance on the outcome of critically ill patients – preliminary results and exploratory economic evaluation
Moreira, C. E. N., Padovesi, C. M., Sales, V. V. T., Holdack, P. J. F., Furlan, M. M. D., Tavares, M. S., Carnielo, M. T., & Bianco, A. D. M. (2026) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-026-00721-4 · Cited by 4
Comparison of Simulated Outcomes of Colorectal Cancer Surgery at the Highest-Performing vs Chosen Local Hospitals
Finn, C. B., Wirtalla, C. J., Roberts, S. E., Collier, K. T., Mehta, S. J., Guerra, C. E., Airoldi, E. M., Zhang, X., Keele, L. J., Aarons, C. B., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55999 · Cited by 4
Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
Lu, B., Dai, W. F., Croxford, R., Isaranuwatchai, W., Beca, J. M., Menjak, I. B., Petrella, T. M., Mittmann, N., Earle, C. C., Gavura, S., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5862 · Cited by 4
Implementation of an online pain science education for chronic musculoskeletal pain in Brazilian public health system: protocol for a hybrid type III randomised controlled trial with economic evaluation
Baroni, M. P., Hespanhol, L., Miyamoto, G. C., Daniel, C. R., Fernandes, L. G., dos Reis, F. J. J., Pate, J. W., & Saragiotto, B. T. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06360-7 · Cited by 7
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial—THRIVE trial
Machin, M., Whittley, S., Norrie, J. D., Burgess, L., Hunt, B. J., Saghdaoui, L. B., Shalhoub, J., Everington, T., Gohel, M., Whiteley, M. S., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083488 · Cited by 4
Unveiling the truth: is COVID-19 reimbursement in Colombia a flawed design? A cost-of-illness analysis for moderate, severe and critical infections
Fernández‐Trujillo, L., Sangiovanni, S., Castrillón, A. I., Hincapié-Zapata, L., Góez-Mogollón, L. M., Vergara, M. B., & Prada, S. I. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002097 · Cited by 4
Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients
Dewi, P. E. N., Thavorncharoensap, M., & Rahajeng, B. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00478-2 · Cited by 4
Balloon Spacer Implant Is an “Intermediate Value” Innovation Relative to Partial Repair for Full‐Thickness Massive Rotator Cuff Repairs: A Cost‐Utility Analysis
Wang, K. Y., Kishan, A., Abboud, J. A., Verma, N. N., & Srikumaran, U. (2024) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2024.06.023 · Cited by 4
Quantifying the cost savings and health impacts of improving colonoscopy quality: an economic evaluation
McCarthy, S., Rutter, M. D., McMeekin, P. J., Catlow, J., Sharp, L., Brookes, M., Valori, R., Bhardwaj-Gosling, R., Lee, T., McNally, R., et al. (2024) · BMJ Quality & Safety · doi:10.1136/bmjqs-2023-016932 · Cited by 4
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy
Paulissen, J. H. J., van Schoonhoven, A. V., Olin, E., Postma, A. J., Mbanya, Z., Dunton, K., Postma, M. J., van Hulst, M., & Freriks, R. (2024) · Advances in Therapy · doi:10.1007/s12325-024-03033-2 · Cited by 4
Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis
Hoog, C. J. P. O. ’., Bosman, S., Boerrigter, E., Mehra, N., van Oort, I. M., van Erp, N. P., & Kievit, W. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241305084 · Cited by 5
Economic burden of acute kidney injury in children and adults: a protocol for a systematic review and meta-analysis
Ulrich, E. H., Lillywhite, A., Alobaidi, R., Morgan, C., Paulden, M., Zappitelli, M., & Bagshaw, S. M. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087513 · Cited by 4
Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy
Costanzo, A. D., Loreto Spencer, L., Vassallo, C., & Fiorentino, F. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s495401 · Cited by 4
Estimation of non-health gross domestic product (NHGDP) loss due to COVID-19 deaths in West Bengal, India
Bhattacharya, P., John, D., Mukherjee, N., Narassima, M. S., Menon, J. C., & Banerjee, A. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072559 · Cited by 4
Secondary Prevention via Case Managers in Stroke Patients: A Cost-Effectiveness Analysis of Claims Data from German Statutory Health Insurance Providers
Düvel, J. A., Gruhn, S., Grosser, J., Elkenkamp, S., & Greiner, W. (2024) · Healthcare · doi:10.3390/healthcare12111157 · Cited by 4
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs
Michaeli, D. T., & Michaeli, T. (2024) · PharmacoEconomics · doi:10.1007/s40273-024-01448-x · Cited by 4
Health economic studies in clinical rehabilitation: A new collection of papers and a discussion of issues involved in research
Wade, D. T. (2025) · Clinical Rehabilitation · doi:10.1177/02692155251381743 · Cited by 4
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review
Trigg, L. A., Farmer, C., Muthukumar, M., Wilson, E., Lovell, A., & Lee, D. (2025) · Applied Health Economics and Health Policy · doi:10.1007/s40258-025-00975-8 · Cited by 3
A cost-utility analysis of pharmacopuncture versus physiotherapy for chronic low back pain: A multicenter, pragmatic randomized controlled trial
Lee, Y., Kim, S. J., Park, K. S., Lee, Y. J., Yang, C., Han, C.-H., & Ha, I. (2025) · Integrative Medicine Research · doi:10.1016/j.imr.2025.101210 · Cited by 3
Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis
Kim, C., Sweeney, S., Sohn, H., Knight, G. M., & McQuaid, C. F. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005275 · Cited by 3
Economic burden and cost drivers of interstitial lung disease: a systematic review
Chiew, S. Y., Mohammed, M., & Ong, S. C. (2025) · The European Journal of Health Economics · doi:10.1007/s10198-025-01836-w · Cited by 4
Economic Evaluations of Medication Safety Interventions in Primary and Long-Term Care: A Systematic Review
Amritlal, S. T., Chandler, R., Ahari, A. M., Paterson, L., Avery, A. J., Ashcroft, D. M., Chuter, A., & Elliott, R. A. (2025) · PharmacoEconomics · doi:10.1007/s40273-025-01567-z · Cited by 3
Potential change in healthcare costs of implementing artificial intelligence for detecting cervical spine fractures on CT: an early health technology assessment
van den Wittenboer, G. J., Nijholt, I. M., Kvamme, I., van Lieshout, C., Maas, M. M., & Boomsma, M. F. (2026) · European Radiology · doi:10.1007/s00330-025-12255-z · Cited by 3
Breaking barriers in women’s pelvic health: claims-based economic analysis and healthcare utilization of an AI care program compared to usual care
Pereira, A. P., Seet, A. M., Domingues, B., Janela, D., Pradhan, A., Areias, A. C., Tong, X., Bento, V., Yanamadala, V., Cohen, S., et al. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2627835 · Cited by 3
Development of living evidence-informed guidelines, part 4
Verdugo‐Paiva, F., Urquhart, O., Bhosale, A. S., Martins-Pfeifer, C. C., Glick, M., & Carrasco‐Labra, A. (2026) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2025.09.011 · Cited by 3
Study protocol for an economic evaluation and budget impact of implementation strategies to support routine provision of antenatal care for gestational weight gain: a stepped-wedge cluster trial
Wynne, O., Szewczyk, Z., Hollis, J., Farragher, E., Doherty, E. L., Tully, B., Paolucci, F., Gillham, K. E., Reeves, P., Wiggers, J. H., et al. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00420-8 · Cited by 3
Basics of health economics for clinical trials in orthopaedic trauma
Walter, N., Hierl, K., Rupp, M., & Alt, V. (2023) · Injury · doi:10.1016/j.injury.2023.110878 · Cited by 3
A Network of Sites and Upskilled Therapists to Deliver Best-Practice Stroke Rehabilitation of the Arm: Protocol for a Knowledge Translation Study
Carey, L. M., Cahill, L. S., Blennerhassett, J. M., Nilsson, M., Lannin, N. A., Thijs, V., Hillier, S., Cadilhac, D. A.-M., Donnan, G. A., Morris, M. E., et al. (2023) · Healthcare · doi:10.3390/healthcare11233080 · Cited by 3
Incremental net monetary benefit of using varenicline for smoking cessation: A systematic review and meta‐analysis of economic evaluation studies
Chaisai, C., Patikorn, C., Thavorn, K., Lee, S. W. H., Chaiyakunapruk, N., & Veettil, S. K. (2024) · Addiction · doi:10.1111/add.16464 · Cited by 3
Self-citation
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial
Borsoi, L., Listorti, E., & Ciani, O. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00519-1 · Cited by 3
Cost-Effectiveness of [177Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 Trials
Holzgreve, A., Unterrainer, L. M., Tiling, M., Mansour, N., Spitzweg, C., Brendel, M., Ricke, J., Unterrainer, M., Kunz, W. G., & Mehrens, D. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.269416 · Cited by 3
Economic Impact of Digital Musculoskeletal Care Versus In-person Physical Therapy: A US Claims Analysis of Health Care Utilization and Outcomes
Pereira, A. P. D., Seet, A. M., Janela, D., Pradhan, A., Areias, A. C., Domingues, B., Bento, V., Yanamadala, V., Cohen, S. P., Correia, F. D., et al. (2025) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2025.09.010 · Cited by 3
Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment
Zaim, R., Redekop, K., & Groot, C. A. U. (2023) · Frontiers in Health Services · doi:10.3389/frhs.2023.1034256 · Cited by 3
Cost-effectiveness analysis of the treatment with compressive therapy in the healing of venous ulcers
Sodré, S. L. S., Nogueira, G. D. A., de Abreu, A. M., Marta, C. B., Peregrino, A. A. D. F., & da Silva, R. C. L. (2023) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.6017.3840 · Cited by 3
Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand
Grant, A., Tan, C. J., Wattanasirichaigoon, S., Rungruanghiranya, S., Thongphiew, A., Thavorn, K., & Chaiyakunapruk, N. (2023) · Tobacco Induced Diseases · doi:10.18332/tid/161024 · Cited by 3
Self-citation
Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong
Peng, K., Li, Y., Chan, E. W., Wong, I. C. K., & Li, X. (2023) · Value in Health Regional Issues · doi:10.1016/j.vhri.2023.02.003 · Cited by 3
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review
Tefera, B. B., Demsie, D. G., Yehualaw, A., Tafere, C., Feyisa, K., Yismaw, M. B., Kefale, B., & Yilma, Z. (2023) · PharmacoEconomics - Open · doi:10.1007/s41669-023-00433-y · Cited by 3
Modeling the impact of a long‐term horizon and multiple treatment episodes on estimates of the cost‐effectiveness of alcohol treatment in the United States
Barbosa, C., Dowd, W. N., Karriker‐Jaffe, K. J., & Zarkin, G. A. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15186 · Cited by 3
[Clinical practice guidelines for meropenem therapy in neonatal sepsis (2024)].
(2024) · PubMed Central · doi:10.7499/j.issn.1008-8830.2309059 · Cited by 3
Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies
Pratama, A. P., Chen, S.-F., Liao, S.-C., Su, W.-C., & Yu, J. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.05.032 · Cited by 3
Comparing the cost-effectiveness of the MPT64-antigen detection test to Xpert MTB/RIF and ZN-microscopy for the diagnosis of Extrapulmonary Tuberculosis: An economic evaluation modelling study
Hassan, S., Mustafa, T., Muller, W., Torres, L., Marijani, M., Ngadaya, E. S., Mfinanga, S., Lema, Y. L., Grønningen, E., Jørstad, M. D., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003414 · Cited by 3
Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens
Quist, S. W., Dorsthorst, S. T., Freriks, R., Postma, M. J., Hoyng, C. B., & van Asten, F. (2024) · The European Journal of Health Economics · doi:10.1007/s10198-024-01715-w · Cited by 3
Protocol for a Field Trial of a Hearing and Vision Support Intervention for People Living in Long‐Term Care in Australia
Meyer, C., El‐Saifi, N., Rose, N. V., Bail, K. S., Browning, C. J., Cenin, D. R., Ahumada‐Canale, A., Campbell, M. E. J., England, T., Ferguson, M., et al. (2025) · Health Expectations · doi:10.1111/hex.70175 · Cited by 3
Costs and Benefits of the Melbourne Mobile Stroke Unit Compared With Standard Ambulance: Causal Analysis Using Observational Linked Data
Cadilhac, D. A.-M., Birhanu, M. M., Churilov, L. P., Zhao, H. H., Coote, S., Campbell, B. C. V., Langenberg, F., Davis, S. M., Donnan, G. A., Smith, K. L., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.048403 · Cited by 3
Early Rehabilitation Bundle in a Canadian PICU: Cost Analysis of Implementation in 2018–2020
Gertsman, S., Pavalagantharajah, S., Falk, L., Borhan, S., Kennedy, K., Thabane, L., Xie, F., Cupido, C. M., & Choong, K. L. M. (2025) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003806 · Cited by 3
Are Living Guidelines Worth it? Economic Evaluations of National Living Clinical Guidelines for COVID-19 and StrokePreprint
Zomer, E., Tan, E. J., Kim, J., Turner, T., Cadilhac, D. A.-M., Hill, K. M., Zoungas, S., McGloughlin, S., Le, L. L., & Millard, T. N. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5382385 · Cited by 3
Micro-costing from healthcare professional’s perspective and acceptability of cutaneous leishmaniasis diagnostic tools in Morocco: A mixed-methods study
Bennis, I., Sadiki, M., Ezzahidi, A., Laaroussi, N., & Bouhout, S. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002534 · Cited by 2
Cost-Utility Analysis of a School-Based Universal Program for the Prevention of Anxiety, Depression, and Substance Use: The Climate Schools Combined Trial
Chatterton, M. L., Perez, J. K., Lee, Y. Y., Le, L. K., Birrell, L., Slade, T. N., Mewton, L. R., Hides, L. M., MCBRIDE, N. T., ALLSOP, S. J., et al. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01423-9 · Cited by 2
Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study
Kamenský, V., Dostálek, L., Rožánek, M., Tichopád, A., Prymula, R., & Šarkanová, I. (2025) · BMC Public Health · doi:10.1186/s12889-025-21599-6 · Cited by 3
Cost-effectiveness and cost-utility of exposure-based vs. traditional cognitive behavior therapy for fibromyalgia: Results from a randomized controlled trial
Hedman‐Lagerlöf, M., Hedman‐Lagerlöf, E., Buhrman, M., & Axelsson, E. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105375 · Cited by 4
Cost-Effectiveness of an Interdisciplinary, Internet-Based Transgender Health Care Program in Germany: Economic Evaluation Alongside a Randomized Controlled Trial
Grochtdreis, T., König, H., Renner, J., Sehner, S., Dekker, A., Briken, P., Nieder, T. O., & Dams, J. (2025) · Journal of Medical Internet Research · doi:10.2196/66371 · Cited by 2
The hidden economic burden of cancer caring
Gao, L., Mudiyanselage, S. B., Ugalde, A., Watts, J. J., Jongebloed, H., Thomas, S., Das, N., Lyall, A., Winter, N., Cowdery, S. P., et al. (2025) · Cancer · doi:10.1002/cncr.35970 · Cited by 2
Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review
Shono, A., Hoshi, S., & Kondo, M. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2525619 · Cited by 2
Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation
Bailie, C. R., Scott, N., Pedrana, A. E., Hellard, M. E., & Doyle, J. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf514 · Cited by 2
Sugammadex or Neostigmine for prevention of post-operative pulmonary complications after major abdominal or thoracic surgery: study protocol for the SINFONIA (Sugammadex for preventioN oF pOst-operative pulmonary complIcAtions) randomised controlled superiority trial
Silversides, J. A., Savic, L. C., Hiller, L., Hopkins, A., Booth, K., Dorey, J., Smithson, R., Mason, J. M., Frempong, S., May, C., et al. (2025) · Trials · doi:10.1186/s13063-025-08987-4 · Cited by 3
Cost-effectiveness of virtual emergency care models: A protocol for a systematic review
Shankar, R., Wang, L., Ho, S. H., Fong, L. M., Gollamudi, S. P. K., & Wong, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0330946 · Cited by 2
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations
Lee, H., Cho, J., Vietri, J., Dawson, E., & Chaiyakunapruk, N. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2565902 · Cited by 2
Self-citation
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
Glewis, S., Fagery, M., Lingaratnam, S. M., Harris, S., Georgiou, C. L., Underhill, C. R., Warren, M. A., Campbell, R., Martin, J. H., Tie, J., et al. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01489-w · Cited by 2
Community-based mobile tuberculosis clinics in rural Madagascar: impact and cost-effectiveness analysis
Beigel, L., Nguyen, H. T., Allegri, M. D., Franke, M. A., Randrianantoanina, A., Ranjaharinony, F., Etrahagnane, M., Knauß, S., Emmrich, J., & Müller, N. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2025-019436 · Cited by 2
Data-Driven Patient Engagement to Improve Medication Adherence: A Narrative Review of Targeted Outreach Across Health Systems
Onah, C. O., Chukwuemeka, O. A., Yusuff, T. A., Abraham, E. E., Mounange-Badimi, M. S., Oladosu, T. A., & Okpalanwaka, I. F. (2025) · Cureus · doi:10.7759/cureus.95928 · Cited by 3
Breaking down costs: rehabilitation robotics vs. usual care therapy in diverse healthcare models
Gower, V., Hamilton, T., Spinelli, F., Randazzo, M., Aprile, I. G., Falchini, F., Germanotta, M., Gramatica, F., Wagner, T. H., & Krebs, H. I. (2025) · Scientific Reports · doi:10.1038/s41598-025-24656-7 · Cited by 2
Cost-Effectiveness of Pantoprazole to Prevent Upper Gastrointestinal Bleeding in Mechanically Ventilated Patients
Xie, F., Yao, Y., Ma, Y., Humphries, B., Lau, V. I., Fowler, R. A., Rochwerg, B. N., Heels‐Ansdell, D., Zytaruk, N. L., Barletta, J. F., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.52771 · Cited by 2
Healthcare Utilization, Costs, and Cost-Effectiveness of Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomized Controlled, Phase 3, Superiority Trial
Olij, B., da Cunha, G. P., Kimman, M., Ratti, F., Hilal, M. A., Troisi, R. I., Sutcliffe, R. P., Besselink, M. G., Aroori, S., Menon, K. V., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18779-4 · Cited by 2
The Financial Impact of Colorectal Enhanced Recovery After Surgery: A Single‐Centre Retrospective Pre‐Post Cost‐Analysis
Markey, W., Warner, R. E., Blundell, J., & Mills, S. (2025) · ANZ Journal of Surgery · doi:10.1111/ans.70426 · Cited by 2
Cost-Effectiveness of Music for Preventing Postoperative Delirium in Elderly Hip Fracture Patients
Dirven, T. L. A., Becker, A. S., van den Brandeler, H. A., Fu, V. X., Jeekel, J., Klimek, M., Verhofstad, M. H. J., & Poley, M. J. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.11.062 · Cited by 2
Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients
Martins, R., Koyner, J., Wald, R., Harenski, K., & Echeverri, J. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s546850 · Cited by 2
Cost-Effectiveness of First-Line Regimens for Helicobacter pylori Infection in the United States
Liu, L., Wang, K., Neidecker, M. V., Yang, H., & Milap, N. C. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003924 · Cited by 2
Cost-Effectiveness of Surgery Versus Functional Bracing for Humeral Shaft Fractures in Adults
Suter, C., Ibounig, T., Reito, A. R., Mattila, H., Sumrein, B. O., Launonen, A. P., Paavola, M. P., Järvinen, T. L. N., TAIMELA, S. P., Rämö, L., et al. (2026) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.25.00867 · Cited by 2
Cost-effectiveness of digital health interventions for supporting mental health of children and young people: a rapid review and narrative synthesis
Obse, A., Pavarini, G., Fazel, M. S., Ma, M., Fancourt, D. E., Morgan, C., Harriss, E. P., Bhui, K. S., Smith, L., Hugh‐Jones, S., et al. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02932-1 · Cited by 3
Cost-effectiveness of a music therapy intervention for people living with dementia: a model for a UK-based economic evaluation
Eaglestone, G., Stoner, C. R., Pacella, R., & McCrone, P. (2026) · Aging & Mental Health · doi:10.1080/13607863.2026.2639043 · Cited by 2
AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis
Njei, B. M., Tanih, D. N., Al‐Ajlouni, Y. A., Boateng, S., Nguefang, G., & Kanmounye, U. S. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09811-y · Cited by 2
The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation
Huygens, S. A., Versteegh, M., Hemels, M. E. W., Linz, D., Rienstra, M., & Yap, S. (2026) · PharmacoEconomics · doi:10.1007/s40273-026-01604-5 · Cited by 2
Evaluating the cost-effectiveness of Everyday Life Rehabilitation (ELR) for individuals with serious mental illness in supported accommodation
Sjöberg, A., Liv, P., Lindholm, L. H., & Lindström, M. (2026) · The European Journal of Health Economics · doi:10.1007/s10198-026-01905-8 · Cited by 2
Uptake and Costs of the 60‐Day Dispensing Policy for Antihypertensive Medicines in Australia: A Mixed Methods Study
Wang, T., Nguyen, H. L., Tan, I., Picone, D. S., Atkins, E., Gnanenthiran, S. R., Falster, M. O., Pearson, S., Rodgers, A., & Schutte, A. E. (2026) · The Medical Journal of Australia · doi:10.5694/mja2.70167 · Cited by 2
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent β -thalassemia in the United States
Udeze, C., Gargano, M. A., Yang, H., Ogunsile, F. J., Li, N., Fang, H., Jeyakumar, S., & Lopez, A. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2649528 · Cited by 3
Systematic review of economic evaluations for paediatric pulmonary diseases
Chitando, M., Cleary, S., & Cunnama, L. (2023) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-023-00423-1 · Cited by 2
Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
Lourenç�ão, M., Arruda, G. V., Rocha, L. P., Galendi, J. S. C., de Oliveira, J. C., & Jacinto, A. A. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09397-5 · Cited by 2
Should Nicotine Replacement Therapy be Provided Free of Charge? A Cost-Utility Analysis in Sweden
Gebreslassie, M., Galanti, M. R., Feldman, I., & Lager, A. (2023) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntad103 · Cited by 2
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort
Aebersold, H., Foster‐Witassek, F., Aeschbacher, S., Beer, J. H., Blozik, E., Blum, M. R., Bonati, L. H., Conte, G., Coslovsky, M., Perna, M. L. D., et al. (2024) · Open Heart · doi:10.1136/openhrt-2023-002567 · Cited by 2
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit
Alhersh, E., Abushanab, D., Abounahia, F. F., Rainkie, D. C., Hail, M. A., Abdulrouf, P. V., Elkassem, W., & Al‐Badriyeh, D. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2345218 · Cited by 2
Potential health and economic impact of achieving Kenya’s overweight and obesity reduction target: a modelling study
Wanjau, M. N., Aminde, L. N., & Veerman, L. J. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000566 · Cited by 2
Economic evaluations of pancreatic cancer screening: a systematic review protocol
Wittram, R., König, H., & Brettschneider, C. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087003 · Cited by 2

Authors: Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., Mauskopf, J., Mullins, C. D., Petrou, S., Pwu, R.-F., Staniszewska, S., & on behalf of CHEERS 2022 ISPOR Good Research Practices Task Force
Affiliations: University of Ottawa (CA)
University of York (GB)
Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
London School of Hygiene & Tropical Medicine (GB)
Springer Nature (New Zealand) (NZ)
University of Utah (US)
Ben-Gurion University of the Negev (IL)
Harvard University (US)
RTI International (US)
University of Maryland, Baltimore (US)
University of Oxford (GB)
Ministry of Health and Welfare (TW)
University of Warwick (GB)
Corresponding author: Husereau, Don
ORCID: Husereau, Don
Drummond, Michael
Augustovski, Federico
Briggs, Andrew H.
Carswell, Chris
Caulley, Lisa
Chaiyakunapruk, Nathorn
Greenberg, Dan
Loder, Elizabeth
Mauskopf, Josephine
Mullins, C. Daniel
Petrou, Stavros
Pwu, Raoh-Fang
Staniszewska, Sophie
Venue: BMC Medicine
Publisher: Springer Science and Business Media LLC
Published: 2022-01-12
Volume: 20
Issue: 1
Pages: 23-23
ISSN: 1741-7015 (ISSN-L)
DOI: 10.1186/s12916-021-02204-0
PMC: PMC8753858
OpenAlex: W4206071468
Cited by: 450
References: 46
Citations by year: 2026: 125 · 2025: 160 · 2024: 91 · 2023: 65 · 2022: 9
FWCI: 65.35
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: BMC Medicine (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion, other-oa)
EUR Research Repository (Erasmus University Rotterdam) (acceptedVersion, cc-by)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
uO Research (University of Ottawa) (submittedVersion, public-domain)
Funders: National Institute for Health Research Health Protection Research Unit
National Institute for Health and Care Research (NF-SI-0616-10103, NIHR202402)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords: CHEERS 2022, health economic evaluation, reporting guidelines, reporting checklist, stakeholder engagement, patient and public involvement, health technology assessment, transparency in decision-making
MeSH terms: Cost-Benefit Analysis, Delivery of Health Care, Humans, Peer Review, Checklist, Research Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks